Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 34: 268-272, 1988;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pinnaduwage, P.
Right arrow Articles by Huang, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pinnaduwage, P.
Right arrow Articles by Huang, L.

Clinical Chemistry, Vol 34, 268-272, Copyright © 1988 by American Association for Clinical Chemistry

A homogeneous, liposome-based signal amplification for assays involving enzymes

P Pinnaduwage and L Huang
Department of Biochemistry, University of Tennessee, Knoxville 37996- 0840.

Exploiting the fact that phosphatidylethanolamine (PE) liposome can be stabilized by a membrane lipid or protein, and that destruction of this stabilizer leads to rapid lysis of the liposome, we have designed a liposome-based signal enhancement mechanism for assays that involve enzyme as the final read-out step. Stable liposomes with entrapped glucose-6-phosphate dehydrogenase (G6PDH) were prepared with unsaturated PE stabilized with 5 mol percent of ganglioside GM1. Addition of beta-galactosidase caused rapid (3-5 min) lysis of liposomes, revealing the latent G6PDH activity, owing to the enzymatic degalactosylation of GM1. We have used Microgenic's CEDIA assay for digoxin as an example. The magnitude of signal was 25 mA/min per microgram of digoxin per liter for the unamplified assay and 1000 mA/min per microgram of digoxin per liter for the liposome-enhanced assay--i.e., a 40-fold amplification. This simple, rapid, and homogeneous signal-amplification mechanism is likely to be useful in many enzyme-dependent assays, such as ELISA, CEDIA, gene-probe assays, and immunoliposome assays.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by the American Association for Clinical Chemistry.